Prostate cancer epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
In 2012, the [[prevalence]] of prostate cancer was estimated to be 2,800 cases per 100,000 men in the United States. The incidence of prostate cancer is approximately 137.9 per 100,000 individuals worldwide. The majority of prostate cancer cases are reported in the United States. It usually affects individuals of the African American race. Asian, Hispanic and White individuals are less likely to develop prostate cancer. The incidence of Prostate cancer increases with age; the median age at diagnosis is 66 years.
In 2012, the [[prevalence]] of prostate cancer was estimated to be 2,800 cases per 100,000 men in the United States. The [[incidence]] of prostate cancer is approximately 137.9 per 100,000 individuals worldwide. The majority of prostate cancer cases are reported in the United States. It usually affects individuals of the African American race. Asian, Hispanic and White individuals are less likely to develop prostate cancer. The [[incidence]] of Prostate cancer increases with age; the median age at diagnosis is 66 years.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Line 15: Line 15:


===Incidence===
===Incidence===
* The incidence of prostate cancer is approximately 137.9 per 100,000 individuals worldwide. The number of deaths was 21.4 per 100,000 men per year. These rates are age-adjusted and based on 2008-2012 cases and deaths.<ref name=”seer”>National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov</ref>
* The [[incidence]] of prostate cancer is approximately 137.9 per 100,000 individuals worldwide. The number of deaths was 21.4 per 100,000 men per year. These rates are age-adjusted and based on 2008-2012 cases and deaths.<ref name=”seer”>National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov</ref>


* In 2011, the delay-adjusted [[incidence]] of prostate cancer was estimated to be 145.2 per 100,000 men in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
* In 2011, the delay-adjusted [[incidence]] of prostate cancer was estimated to be 145.2 per 100,000 men in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
Line 22: Line 22:


===Age===
===Age===
* The incidence of Prostate cancer increases with age; the median age at diagnosis is 66 years.
* The [[incidence]] of Prostate cancer increases with age; the median age at diagnosis is 66 years.


* While the overall age-adjusted [[incidence]] of prostate cancer in the United States between 2007 and 2011 is 147.6 per 100,000, the age-adjusted [[incidence]] of prostate cancer by age category is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
* While the overall age-adjusted [[incidence]] of prostate cancer in the United States between 2007 and 2011 is 147.6 per 100,000, the age-adjusted [[incidence]] of prostate cancer by age category is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>

Revision as of 19:20, 15 September 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Prostate cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prostate Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Staging

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Alternative Therapy

Case Studies

Case #1

Prostate cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prostate cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prostate cancer epidemiology and demographics

CDC on Prostate cancer epidemiology and demographics

Prostate cancer epidemiology and demographics in the news

Blogs on Prostate cancer epidemiology and demographics

Directions to Hospitals Treating Prostate cancer

Risk calculators and risk factors for Prostate cancer epidemiology and demographics

Overview

In 2012, the prevalence of prostate cancer was estimated to be 2,800 cases per 100,000 men in the United States. The incidence of prostate cancer is approximately 137.9 per 100,000 individuals worldwide. The majority of prostate cancer cases are reported in the United States. It usually affects individuals of the African American race. Asian, Hispanic and White individuals are less likely to develop prostate cancer. The incidence of Prostate cancer increases with age; the median age at diagnosis is 66 years.

Epidemiology and Demographics

Prevalence

  • In 2012, there were an estimated 2,800 per 100,000 men living with prostate cancer in the United States.[1]
  • In the United States, the age-adjusted prevalence of prostate cancer is 1,690 per 100,000 in 2011.[2]
  • Rates of prostate cancer vary widely across the world. Although the rates vary widely between countries, it is least common in South and East Asia, more common in Europe, and most common in the United States.[3]

Incidence

  • The incidence of prostate cancer is approximately 137.9 per 100,000 individuals worldwide. The number of deaths was 21.4 per 100,000 men per year. These rates are age-adjusted and based on 2008-2012 cases and deaths.[1]
  • In 2011, the delay-adjusted incidence of prostate cancer was estimated to be 145.2 per 100,000 men in the United States.[2]
  • In 2011, the age-adjusted incidence of prostate cancer was 139.89 per 100,000 men in the United States.[2]

Age

  • The incidence of Prostate cancer increases with age; the median age at diagnosis is 66 years.
  • While the overall age-adjusted incidence of prostate cancer in the United States between 2007 and 2011 is 147.6 per 100,000, the age-adjusted incidence of prostate cancer by age category is:[2]
    • Under 65 years: 57.8 per 100,000
    • 65 and over: 768.2 per 100,000
  • Shown below is an image depicting the incidence of prostate cancer by age and race in the United States between 1975 and 2011.[2]

Delay adjusted incidence and observed incidence in prostate cancer by age and race in USA

Race

  • It usually affects individuals of the African American race. Asian, Hispanic and White individuals are less likely to develop prostate cancer.[4][5]
  • Shown below is a table depicting the age-adjusted prevalence of prostate cancer by race in 2011 in the United States.[2]
All Races White Black Asian/Pacific Islander Hispanic
Age-adjusted prevalence 1690 per 100,000 1680 per 100,000 2610 per 100,000 870 per 100,000 1320 per 100,000
  • Shown below is an image depicting the incidence of prostate cancer by race in the United States between 1975 and 2011.[2]

Incidence of prostate cancer per race in USA

API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native

References

  1. ↑ 1.0 1.1 National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov
  2. ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  3. ↑ "IARC Worldwide Cancer Incidence Statistics—Prostate". JNCI Cancer Spectrum. Oxford University Press. December 19, 2001. Retrieved on 2007-04-05 through the Internet Archive
  4. ↑ Overview: Prostate Cancer—What Causes Prostate Cancer? American Cancer Society (2006-05-02). Retrieved on 2007-04-05
  5. ↑ Prostate Cancer FAQs. State University of New York School of Medicine Department of Urology (2006-08-31). Retrieved on 2007-04-05

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Prostate_cancer_epidemiology_and_demographics&oldid=1156792"